ArticleJournal of clinical and experimental hematopathology : JCEH2025
Pemigatinib therapy in myeloid/lymphoid neoplasm with FGFR1 rearrangement manifesting as aggressive B-cell lymphoma.
Kenichi Ito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.